Directory Tag: Linahert 5

Linahert D5/10 Tablet is a combination medication designed for Type 2 diabetes management, formulated by Hertz Pharma. It combines Linagliptin (5 mg) and Dapagliflozin (10 mg), two powerful antidiabetic agents that work together to improve blood sugar control. Linagliptin, a DPP-4 inhibitor, enhances insulin secretion and reduces glucose production, while Dapagliflozin, an SGLT2 inhibitor, promotes glucose excretion through urine. This dual mechanism helps achieve better glycemic control, making Linahert D5/10 an effective option for patients who need additional support beyond diet and exercise.